相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
Yelena Y. Janjigian et al.
CANCER DISCOVERY (2018)
Molecular classification and precision therapy of cancer: immune checkpoint inhibitors
Yingyan Yu
FRONTIERS OF MEDICINE (2018)
Two immune-enhanced molecular subtypes differ in inflammation, checkpoint signaling and outcome of advanced head and neck squamous cell carcinoma
Bangrong Cao et al.
ONCOIMMUNOLOGY (2018)
Analysis of PD1, PDL1, PDL2 expression and T cells infiltration in 1014 gastric cancer patients
Xiaofang Xing et al.
ONCOIMMUNOLOGY (2018)
Pembrolizumab for treatment of advanced gastric and gastroesophageal junction adenocarcinoma
Smita S. Joshi et al.
FUTURE ONCOLOGY (2018)
The Transcriptomic Landscape of Gastric Cancer: Insights into Epstein-Barr Virus Infected and Microsatellite Unstable Tumors
Irene Gullo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
A proteomic landscape of diffuse-type gastric cancer
Sai Ge et al.
NATURE COMMUNICATIONS (2018)
Immunization With Fc-Based Recombinant Epstein-Barr Virus gp350 Elicits Potent Neutralizing Humoral Immune Response in a BALB/c Mice Model
Bingchun Zhao et al.
FRONTIERS IN IMMUNOLOGY (2018)
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer Phase 2 Clinical KEYNOTE-059 Trial
Charles S. Fuchs et al.
JAMA ONCOLOGY (2018)
Immune Monitoring of Cancer Patients Prior to and During CTLA-4 or PD-1/PD-L1 Inhibitor Treatment
Antje Tunger et al.
BIOMEDICINES (2018)
Update in Systemic and Targeted Therapies in Gastrointestinal Oncology
Nelson S. Yee
BIOMEDICINES (2018)
A positive crosstalk between CXCR4 and CXCR2 promotes gastric cancer metastasis
Z. Xiang et al.
ONCOGENE (2017)
Masterful Antibodies: Checkpoint Blockade
Nils Lonberg et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Expression profiles of immune-related genes are associated with neoadjuvant ipilimumab clinical benefit
Ahmad A. Tarhini et al.
ONCOIMMUNOLOGY (2017)
Host immune response index in gastric cancer identified by comprehensive analyses of tumor immunity
Charny Park et al.
ONCOIMMUNOLOGY (2017)
Intrinsic Resistance of Solid Tumors to Immune Checkpoint Blockade Therapy
Xianda Zhao et al.
CANCER RESEARCH (2017)
Prognostic value of tumor-infiltrating lymphocytes in Epstein-Barr virus-associated gastric cancer
B. W. Kang et al.
ANNALS OF ONCOLOGY (2016)
Cancer immunotherapy: the beginning of the end of cancer?
Sofia Farkona et al.
BMC MEDICINE (2016)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade
Pei-Ling Chen et al.
CANCER DISCOVERY (2016)
Intratumoral expression levels of PD-L1, GZMA, and HLA-A along with oligoclonal T cell expansion associate with response to nivolumab in metastatic melanoma
Hiroyuki Inoue et al.
ONCOIMMUNOLOGY (2016)
Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis
Anne Bertrand et al.
BMC MEDICINE (2015)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
Razvan Cristescu et al.
NATURE MEDICINE (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M. Van Allen et al.
SCIENCE (2015)
Overexpression of E2F mRNAs Associated with Gastric Cancer Progression Identified by the Transcription Factor and miRNA Co-Regulatory Network Analysis
XiaoTian Zhang et al.
PLOS ONE (2015)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Gabriela Bindea et al.
IMMUNITY (2013)
An immune-active tumor microenvironment favors clinical response to ipilimumab
Rui-Ru Ji et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Cutting Edge: CTLA-4 on Effector T Cells Inhibits In Trans
Emily Corse et al.
JOURNAL OF IMMUNOLOGY (2012)
Management of advanced gastric cancer
Timothy J. Price et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2012)
A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
Omid Hamid et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Gene-Expression Signatures Can Distinguish Gastric Cancer Grades and Stages
Juan Cui et al.
PLOS ONE (2011)
Phase II Trial of Tremelimumab (CP-675,206) in Patients with Advanced Refractory or Relapsed Melanoma
John M. Kirkwood et al.
CLINICAL CANCER RESEARCH (2010)
Modulation of Lymphocyte Regulation for Cancer Therapy: A Phase II Trial of Tremelimumab in Advanced Gastric and Esophageal Adenocarcinoma
Christy Ralph et al.
CLINICAL CANCER RESEARCH (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Intratumour T cells, their activation status and survival in gastric carcinomas characterised for microsatellite instability and Epstein-Barr virus infection
AM Chiaravalli et al.
VIRCHOWS ARCHIV (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Lymphocyte-rich gastric cancer: Associations with Epstein-Barr virus, microsatellite instability, histology, and survival
KL Grogg et al.
MODERN PATHOLOGY (2003)
分享论文
